
Results
62
62 companies
Incyte
Market Cap: US$25.0b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$123.47
7D
2.0%
1Y
44.5%
Exelixis
Market Cap: US$13.2b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$53.12
7D
5.4%
1Y
40.3%
Orion Oyj
Market Cap: €11.0b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€79.10
7D
1.5%
1Y
13.6%
CSPC Innovation Pharmaceutical
Market Cap: CN¥60.1b
Engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.
300765
CN¥43.15
7D
0.9%
1Y
-12.1%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥52.4b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥116.48
7D
-0.7%
1Y
29.0%
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥42.1b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥46.98
7D
0.4%
1Y
26.5%
Abbott India
Market Cap: ₹561.0b
Operates as a pharmaceutical company in India.
500488
₹26,400.00
7D
-6.2%
1Y
-19.1%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹514.0b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹3,034.05
7D
15.8%
1Y
8.9%
3SBio
Market Cap: HK$41.6b
An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.
1530
HK$16.69
7D
-5.3%
1Y
-45.2%
ACADIA Pharmaceuticals
Market Cap: US$5.0b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$30.18
7D
2.6%
1Y
20.9%
Ajanta Pharma
Market Cap: ₹462.0b
A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.
AJANTPHARM
₹3,697.90
7D
4.4%
1Y
37.8%
Suzhou Zelgen Biopharmaceuticals
Market Cap: CN¥32.4b
Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.
688266
CN¥122.54
7D
2.2%
1Y
15.7%
SK Biopharmaceuticals
Market Cap: ₩6.7t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩85,300.00
7D
-3.3%
1Y
-12.1%
Xiamen Amoytop Biotech
Market Cap: CN¥26.3b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥64.40
7D
8.5%
1Y
-25.0%
Sumitomo Pharma
Market Cap: JP¥605.8b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,350.50
7D
0.04%
1Y
-2.2%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€59.70
7D
3.3%
1Y
4.1%
Neuland Laboratories
Market Cap: ₹298.9b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹23,296.85
7D
3.5%
1Y
69.8%
Jamjoom Pharmaceuticals Factory
Market Cap: ر.س10.0b
Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.
4015
ر.س142.40
7D
0.6%
1Y
-10.9%
CareDx
Market Cap: US$2.4b
Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
CDNA
US$46.18
7D
-2.2%
1Y
299.1%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥14.3b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥40.10
7D
-5.0%
1Y
-9.8%
ADMA Biologics
Market Cap: US$2.1b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$9.54
7D
-3.7%
1Y
-45.3%
HBM Holdings
Market Cap: HK$12.6b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$14.49
7D
-3.6%
1Y
25.8%
Innoviva
Market Cap: US$1.5b
Operates as a biopharmaceutical company in the United States and internationally.
INVA
US$21.25
7D
2.4%
1Y
3.6%
CORONA Remedies
Market Cap: ₹129.7b
A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.
CORONA
₹2,121.40
7D
-0.7%
1Y
n/a
MeiraGTx Holdings
Market Cap: US$1.3b
A clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases.
MGTX
US$13.89
7D
7.2%
1Y
83.7%
ChemoMetec
Market Cap: DKK 8.2b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 485.00
7D
4.0%
1Y
-6.6%
BioGaia
Market Cap: SEK 11.7b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 115.00
7D
3.0%
1Y
20.7%
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,100.00
7D
-1.8%
1Y
15.6%
Basilea Pharmaceutica
Market Cap: CHF 739.2m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 62.50
7D
18.8%
1Y
32.1%
Soho Global Health
Market Cap: Rp15.0t
Together with its subsidiaires, operates as a healthcare company in Indonesia.
SOHO
Rp1,185.00
7D
0.4%
1Y
63.4%
Zevra Therapeutics
Market Cap: US$684.7m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$11.57
7D
2.0%
1Y
28.5%
CorMedix
Market Cap: US$636.4m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$8.17
7D
15.1%
1Y
-39.6%
Q32 Bio
Market Cap: US$474.8m
A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.
QTTB
US$15.29
7D
-0.8%
1Y
744.8%
Rafa Laboratories
Market Cap: ₪1.4b
A pharmaceutical company, manufactures, markets, and distributes prescription (Rx) and over-the-counter (OTC) medicines in Israel.
RAFA
₪14.48
7D
-1.7%
1Y
n/a
DHG Pharmaceutical
Market Cap: ₫12.3t
Engages in the manufacture and sale of pharmaceutical products in Vietnam.
DHG
₫93,800.00
7D
-1.9%
1Y
-8.0%
Onconic Therapeutics
Market Cap: ₩635.7b
Engages in the research and development of anti-cancer therapy in South Korea.
A476060
₩14,000.00
7D
-11.4%
1Y
127.6%